https://www.indianpharmapost.com/supriya-lifescience-posts-q3-fy25-pat-up-at-rs-4678-cr-167132025-01-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/torrent-pharmaceuticals-posts-q3-fy25-consolidated-pat-at-rs-503-cr-167142025-01-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/rpg-life-sciences-posts-q3-fy25-pat-higher-at-rs-3493-cr-167152025-01-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/laurus-labs-posts-q3-fy25-consolidated-pat-higher-at-rs-9230-cr-167162025-01-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/mankind-pharma-launches-45-day-healthcare-mission-at-mahakumbh-167172025-01-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/toray-develops-membrane-doubling-filtration-for-biopharmaceutical-manufacturing-processes-167182025-01-28T00:00:00+05:30always0.9